We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRMB:NYSEPrimo Brands Corporation Analysis

Data as of 2026-06-07 - not real-time

$22.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Primo Brands is currently trading below its short‑term momentum gauge, with the price sitting beneath the 20‑day moving average while still above the 50‑day level, indicating a mixed technical picture. The MACD histogram remains in negative territory and the signal line suggests bearish momentum, yet the overall trend is still classified as bullish and the RSI hovers around a neutral midpoint. Volatility is notably elevated, and the stock’s beta points to modest sensitivity to broader market moves. Fundamentally, the valuation appears stretched as the trailing PE is exceptionally high, though the forward PE contracts sharply, hinting at potential earnings improvement. The dividend payout exceeds earnings, raising concerns about the sustainability of the current yield. Additionally, the balance sheet is heavily leveraged with a debt‑to‑equity ratio well above industry norms, while analyst consensus remains positive with a target price that suggests modest upside.
Given the convergence of technical weakness, high leverage, and dividend sustainability issues, investors should approach the stock cautiously. The upside potential is limited unless earnings accelerate and the capital structure improves, but the brand portfolio and defensive consumer positioning provide a degree of resilience. Monitoring margin trends and any deleveraging actions will be key to reassessing the investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day SMA and negative MACD histogram
  • Margin pressure despite earnings beat
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE suggests earnings improvement
  • Analyst target price implies upside
  • Defensive consumer sector offers stability

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt‑to‑equity ratio
  • Dividend payout exceeds earnings
  • Brand portfolio and market position remain solid

Key Metrics & Analysis

Financial Health

Revenue Growth0.80%
Profit Margin0.88%
P/E Ratio120.8
ROE2.32%
ROA4.06%
Debt/Equity193.10
P/B Ratio2.8
Op. Cash Flow$749.5M
Free Cash Flow$415.5M

Technical Analysis

TrendBullish
RSI50.4
Support$22.06
Resistance$25.28
MA 20$23.64
MA 50$21.27
MA 200$20.21
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value$0.71
Target Price$27.18
Upside/Downside18.44%
GradeOvervalued
TypeBlend
Dividend Yield2.09%

Risk Assessment

Beta0.72
Volatility48.89%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.